We are live on ! Find out more
SANA icon

Sana Biotechnology
SANA

178 hedge funds and large institutions have $582M invested in Sana Biotechnology in 2025 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 66 increasing their positions, 36 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

119% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 21

83% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 36

46% more capital invested

Capital invested by funds: $398M → $582M (+$184M)

15% more funds holding

Funds holding: 155 → 178 (+23)

4.3% more ownership

Funds ownership: 64.52% → 68.82% (+4.3%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

11% less call options, than puts

Call options by funds: $1.48M | Put options by funds: $1.66M

Holders
178
Holders Change
+23
Holders Change %
+14.84%
% of All Funds
2.34%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
46
Increased
66
Reduced
36
Closed
21
Calls
$1.48M
Puts
$1.66M
Net Calls
-$183K
Net Calls Change
-$973K

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$13.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$13M
3
Citadel Advisors
Citadel Advisors
Florida
+$13M
4
Renaissance Technologies
Renaissance Technologies
New York
+$6.47M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$5.49M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$8.72M
2
Morgan Stanley
Morgan Stanley
New York
-$2.18M
3
CM
Crestline Management
Texas
-$2.17M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$1.92M
5
Corient Private Wealth
Corient Private Wealth
Florida
-$1.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
SS
151
SBI Securities
Japan
$17.2K +$5.46K +1,510 +45%
AB
152
Amalgamated Bank
New York
$16K – – –
S
153
SignatureFD
Georgia
$12.4K – – –
EWA
154
EverSource Wealth Advisors
Alabama
$12.1K -$69 -19 -0.6%
EP
155
Essential Partners
California
$11.7K +$11 +3 +0.1%
TWD
156
True Wealth Design
Ohio
$8.84K – – –
FFA
157
Farther Finance Advisors
California
$7.1K -$11.1K -3,064 -61%
HC
158
Hurley Capital
New York
$7.1K +$7.23K +2,000 New
Optiver Holding
159
Optiver Holding
Netherlands
$6.53K +$6.59K +1,822 +10,718%
BNP Paribas Asset Management
160
BNP Paribas Asset Management
France
$6K +$5.73K +1,586 New
AT
161
Arlington Trust
Alabama
$5.4K – – –
QCG
162
Quadrant Capital Group
Ohio
$5.25K +$5.35K +1,480 New
WANY
163
Wealthspire Advisors (New York)
New York
$3.66K +$3.72K +1,030 New
AF
164
Allworth Financial
California
$3.59K +$1.66K +459 +83%
PWA
165
Physician Wealth Advisors
Utah
$3.46K – – –
GLF
166
Groupe la Francaise
France
$3.01K +$3.62K +1,000 New
Daiwa Securities Group
167
Daiwa Securities Group
Japan
$3K – – –
US Bancorp
168
US Bancorp
Minnesota
$2.08K -$307 -85 -13%
SAM
169
Smartleaf Asset Management
Massachusetts
$1.88K +$1.25K +346 +186%
MCM
170
MAI Capital Management
Ohio
$1.68K – – –
RIL
171
Rothschild Investment LLC
Illinois
$1.1K – – –
PA
172
Pineridge Advisors
Missouri
$710 +$723 +200 New
PFBT
173
Parkside Financial Bank & Trust
Missouri
$661 – – –
BCWM
174
Bartlett & Co Wealth Management
Ohio
$355 – – –
FGAM
175
Financial Gravity Asset Management
Texas
$355 +$362 +100 New
4 5 6
7
8

SANA Hedge Fund Activity: Q3 2025 in Review

178 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Sana Biotechnology (SANA) for Q3 2025, worth a combined $582M — up 46% from $398M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new SANA positions and 21 closed out — a net gain of 25 holders — while 66 added to existing stakes and 36 trimmed.

The largest buyer was State Street, adding an estimated $13.8M. The largest seller was T. Rowe Price Associates, cutting an estimated $8.72M.

  • 178 institutional investors held Sana Biotechnology (SANA) as of Q3 2025, up from 155 in Q2 2025.
  • Funds reported $582M of Sana Biotechnology stock for Q3 2025, up 46% quarter-over-quarter.
  • 46 funds opened new Sana Biotechnology positions in Q3 2025 and 21 closed out, a net change of +25 holders.
  • The largest Sana Biotechnology buyer in Q3 2025 was State Street, an estimated $13.8M added.
  • The largest Sana Biotechnology seller in Q3 2025 was T. Rowe Price Associates, an estimated $8.72M sold.

Based on aggregated 13F filings for Q3 2025.